Medicash, the UK’s leading provider of corporate health cash plans, has delivered an outstanding performance in 2025, achieving strong growth across customer numbers, financial results and social impact, while accelerating its strategy to reach one million policyholders by 2030.

During the year, Medicash increased its policyholder base by 55,000 to 696,000, reflecting sustained demand from employers for accessible, affordable healthcare solutions that support workforce wellbeing.

Financial performance was equally strong. Technical income grew by 14% to £70.9 million, while technical surplus more than doubled to £3.8 million. Investment returns increased to £4.5 million and group reserves rose by 12% to £59.8 million, further strengthening the organisation’s financial platform and enabling continued investment in innovation and growth.

Alongside this commercial success, Medicash continued to expand its social impact. Through the Medicash Foundation, more than £400,000 was donated during the year, supporting over 140,000 people in communities across the UK.

Building on this momentum, Medicash will introduce a range of new services, available at no additional cost to existing customers, alongside the launch of an innovative new wellbeing product. Further details will be announced in early May. These developments are designed to strengthen its competitive position, enhance its preventative health proposition and deliver even greater value to employers and their people.

The organisation’s ambition is to support one million customers by 2030, alongside a commitment to increase annual charitable giving to at least £750,000 through the Medicash Foundation.

Andrew Healy MBE, Chief Executive, said:

“2025 has been a landmark year for Medicash. We have delivered outstanding commercial performance, strengthened our financial foundations and senior team, enhanced our governance frameworks and, crucially, extended our positive impact in communities across the country.

“We are seeing growing demand from employers who want high-quality, accessible healthcare solutions for their people. With a clear strategy, a strong balance sheet and a pipeline of new products ready to launch, we are well positioned to accelerate our growth.

“Our ambition to reach one million customers by 2030 is bold, but it is entirely achievable. We are building a business with the scale and capability to make an even greater difference to the health and wellbeing of working people.”

Andy Roberts, Chief Operating Officer, added:

“These results reflect the strength, discipline and scalability of our operating model.

“Over the past year, we have accelerated investment in our digital capabilities and continued to modernise our operations, ensuring we can deliver consistent, high-quality service at scale.

“As we look ahead, our focus is on converting that capability into even greater value for employers. The new products and enhancements we will announce in early May represent a major step-change in our proposition – broadening our preventative health offering, increasing flexibility and reinforcing our position as a leading, forward-thinking partner to employers in a rapidly evolving market.”

With a heritage spanning more than 155 years, Medicash remains committed to its enduring purpose: improving the health and wellbeing of its customers, colleagues and communities – while building a modern, resilient organisation fit for the future.